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Abstract
There are many different proposed procedures for sample size planning for the Wilcoxon-
Mann-Whitney test at given type-I and type-II error rates α and β, respectively. Most
methods assume very specific models or types of data in order to simplify calculations
(for example, ordered categorical or metric data, location shift alternatives, etc.). We
present a unified approach that covers metric data with and without ties, count data,
ordered categorical data, and even dichotomous data. For that, we calculate the un-
known theoretical quantities such as the variances under the null and relevant alternative
hypothesis by considering the following “synthetic data” approach. We evaluate data
whose empirical distribution functions match with the theoretical distribution functions
involved in the computations of the unknown theoretical quantities. Then well-known
relations for the ranks of the data are used for the calculations.
In addition to computing the necessary sample size N for a fixed allocation proportion
t = n1/N , where n1 is the sample size in the first group and N = n1 + n2 is the total
sample size, we provide an interval for the optimal allocation rate t which minimizes
the total sample size N . It turns out that for certain distributions, a balanced design is
optimal. We give a characterization of these distributions. Furthermore we show that
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the optimal choice of t depends on the ratio of the two variances which determine the
variance of the Wilcoxon-Mann-Whitney statistic under the alternative. This is different
from an optimal sample size allocation in case of the normal distribution model.
1. Introduction
The comparison of two independent samples is widespread in medicine, the life sciences in
general, and other fields of research. Arguably, the most popular method is the unpaired
t-test for two sample comparisons. However, its application is limited. For heavy-tailed
or very skewed distributions, use of the t-test is not recommended, especially for small
sample sizes. For ordered categorical data, comparing averages by means of t-tests is
not appropriate at all. For those situations, a nonparametric test such as the Wilcoxon-
Mann-Whitney test is much preferred.
In order to plan a study for such a two sample comparison, we need to know how
many subjects are needed to detect a pre-specified effect at least with probability 1 − β
where β denotes the type-II error probability. If the underlying distributions are normal,
a pre-specified effect might be formulated as a difference of means. Within a general
nonparametric framework, the relative effect (see Section 2) is very often used. But for
a statistics practitioner, it is sometimes difficult to state a relevant effect size to be de-
tected in terms of the nonparametric relative effect. Therefore, we will be using a slightly
different approach. Based on prior information F1 regarding one group, for example
the standard treatment or the control group, one can derive the distribution F2 under
a conjectured (relevant) alternative in cooperation with a subject-matter expert. This
distribution is established in such a way that it features what the subject-matter expert
would quantify as a relevant effect. In other words, the expert may, but does not neces-
sarily have to, provide a (standardized) difference of means as a relevant nonparametric
relative effect on which the Wilcoxon-Mann-Whitney effect is based. Or alternatively,
the subject matter expert may simply provide information on an configuration that the
expert would consider relevant in terms of providing evidence in favour of the research
hypothesis. This information will then be translated into a relevant nonparametric ef-
fect. More details on deriving F2 based on an interpretable effect in order to compute the
nonparametric effect and the variances involved in the sample size planning are given in
Section 4.
For the Wilcoxon-Mann-Whitney test, there already exist many sample size formulas.
However, most of them require for example either continuous data as used in Bu¨rkner et
al. [5], Wang et al. [29], or Noether [18], or they require ordered categorical data as in Fan
[9], Tang [27], Lachin [14], Hilton et al. [11], or Whitehead [30]. For a review of different
methods, we refer to Rahardja et al. [22]. A rather well known method for sample
size calculation in case of continuous data is given by Noether [18] who approximated
the variance under alternative by the variance under the null hypothesis. A similar
approximation was also used by Zhao et al. [31] who generalized Noether’s formula to
allow for ties. For practical application however, this approximation may not always
be appropriate because the variances under null hypothesis and under alternative can
be very different, thus potentially leading to an under- or overpowered study. See, for
example, Shieh et al. [26] for a comparison of Noether’s formula with different alternative
methods.
In some other approaches, the sample size is only calculated under the assumption of
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a proportional odds model for ordered categorical data (e.g. Kolassa [12] or Whitehead
[30], or considering only location shift models for continuous metric data (see, e.g., Rosner
and Glynn [23], Chakraborti et al. [6], Lesaffre et al. [16], Hamilton [10], or Collings
and Hamilton [7], among others). An advantage of our Formula (9) in Section 2 for the
sample size calculation is its generality and practicality. It can be used for metric data
as well as for ordered categorical data, and it even works very well for dichotomous data.
Furthermore, our formula does not assume any special model for the alternatives.
Within the published literature, the sample size formulas bearing most similarity to
ours is those by Wang et al. [29]. However, their approach is limited to continuous
distributions, whereas our approach is based on a unified approach allowing for discrete
and for continuous data.
A completely different way to approach optimality of Wilcoxon-Mann-Whitney tests
has been pursued by Matsouaka et al. [17]. They use a weighted sum of multiple
Wilcoxon-Mann-Whitney tests and determine the optimal weight for each test. Their
aim is not an optimal sample size planning including optimization of the ratio of sample
sizes, but instead they try to optimally combine a primary endpoint with mortality.
In a two sample setting, we sometimes can choose the proportion of subjects in the
first group. That is, we can choose t = n1/N where n1 is the number of subjects in the
first group and N is the total number of subjects. The question that arises is how to
choose t in an optimal way. In Bu¨rkner et al. [5], the optimal t is chosen such that the
power of the Wilcoxon-Mann-Whitney test is maximized for a given sample size N . On
the other hand, in practice, we prefer to choose t in such a way that the total sample
size N is minimized for a specified power 1− β. For the two sample t-test with unequal
variances, Dette and O’Brien [8] showed that the optimal t to maximize the power of the
test is approximately
t ≈ 1
1 + τ
,
where τ = σ1/σ0 is the ratio of standard deviations of the two groups under the hypoth-
esis and under the alternative, respectively. This means that when applying the t-test,
more subjects should be allocated to the group with the higher variance. Bu¨rkner et al.
[5] showed for symmetric, continuous distributions under a location shift model, that a
balanced design is optimal for the Wilcoxon-Mann-Whitney test. For general distribu-
tions, they observed in simulation studies that in many situations, the difference between
using the optimal t and using a balanced design is negligible.
In most publications the generation of the alternative from the reference group is not
discussed and, instead the distribution under the alternative is assumed to be known.
Here, we want to discuss, however, also how we can generate the distribution under the
alternative based on the distribution in the reference group and an interpretable relevant
effect. In order to motivate the method derived in this paper, let us consider an example
with count data, as it appears that most publications on sample size planning focus
on ordered categorical or continuous metric data. In Table 1, the data of an advance
information F1 on a placebo for the number of seizures in an epilepsy trial is given. We
want to base the sample size planning for a new drug on the data X1,1, . . . , X1,28 of the
advance information F1 which comes from a study published by Leppik et al. [15], as well
as Thall and Vail [28]. For these data, we cannot assume a location shift model, as an
absolute reduction of two seizures would be very good for someone with three seizures,
but not really helpful for someone with 20 or more seizures. More appropriate would
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probably be a reduction of the number of seizures by some percentage q, for example
q = 50%. Based on this specified relevant effect F2(x) = F1(x/q), we artificially generate
a new data set X2,1, . . . , X2,28 whose empirical distribution function F̂2(x) is exactly equal
to F2(x). Basically, the number n2 of the artificially generated data is arbitrary (here,
n2 = 28, e.g.) as long as F̂2(x) = F2(x) = F1(x/q). We will refer to such data as
“synthetic” data.
Most of the methods mentioned before cannot be applied to data such as these as
they have been derived under different, restrictive assumptions. In particular, methods
assuming a location-shift model cannot be used here. However, application of the method
proposed in the present paper does not require specific types of data or a specific alter-
native because it is based on the observed data and the generated synthetic data, which
do not need to follow any particular model. See also the Chapter “Keeping Observed
Data as a Theoretical Distribution” in Puntanen et al. [21] for a similar approach in the
parametric case. More details regarding this data set and the sample size calculation can
be found in Section 4.
Number of counts
Advance Information
X1,1, . . . , X1,28 ∼ F1(x) 3, 3, 5, 4, 21, 7, 2, 12, 5, 0, 22, 4, 2, 12
9, 5, 3, 29, 5, 7, 4, 4, 5, 8, 25, 1, 2, 12
Relevant Alternative
X2,k ∼ F2(x) = F1(x/q) 1, 1, 2, 2, 10, 3, 1, 6, 2, 0, 11, 2, 1, 6
4, 2, 1, 14, 2, 3, 2, 2, 2, 4, 12, 0, 1, 6
Table 1: Number of seizures for 28 subjects from the advance information X1,k ∼ F1(x),
k = 1, . . . , 28, and for the relevant effect F2(x) = F1(x/q), where q = 0.5 denotes
the percentage of the relevant reduction of seizures to be detected. This means
X2,k = [q ·X1,k] ∼ F2(x), where [u] denotes the largest integer ≤ u.
The rest of this paper is now organized as follows. We first derive a general sample
size formula and investigate the behavior of the optimal t. That is, we show in which
cases more subjects should be allocated to the first or second group. Then, we apply
this method to several data examples with different types of data and provide power
simulations to show that with the sample size calculated by our method, the simulated
power is at least 1−β. Furthermore, we simulate how the chosen type-I and type-II error
rates affect the value of the optimal allocation rate t.
2. Sample Size Formula
Let X1i ∼ Fi and X2j ∼ F2, i = 1, . . . , n1, j = 1 . . . , n2, be independent random samples
obtained onN different subjects, withN = n1+n2. The cumulative distribution functions
F1 and F2 are understood as their normalized versions, that is Fi(x) =
1
2
(
F+i (x)+F
−
i (x)
)
where F+i denotes the right-continuous, and F
−
i denotes the left continuous cumulative
distribution function. By using the normalized version, we can pursue a unified approach
for continuous and discrete data, no separate formulas “correcting for ties” are necessary.
This unified approach results naturally in the usage of midranks in the formulas for the
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test statistics, see Ruymgaart [24], Akritas, Arnold and Brunner [1], and Akritas and
Brunner [2] for details. With t, we denote the proportion of the N subjects that is
allocated to the first group. That is, n1 = tN and n2 = (1 − t)N . Without loss of
generality, X1i may be regarded as the reference group, and the second group X2i as
the (experimental) treatment group. The Wilcoxon-Mann-Whitney test is based on the
nonparametric relative treatment effect
p =
∫
F1dF2 = P (X11 < X21) +
1
2
P (X11 = X22) (1)
which can be estimated in a natural way by its empirical analog pˆ =
∫
Fˆ1dFˆ2. Here,
Fˆi =
1
2
(Fˆ−i + Fˆ
+
i ) is the normalized empirical cumulative distribution function with
Fˆ−i (x) = n
−1
i
∑ni
j=1 1{Xij<x}, and Fˆ
+
i (x) = n
−1
i
∑ni
j=1 1{Xij≤x} the left and right continuous
empirical cumulative distribution functions for i = 1, 2, respectively. Finally, 1{Xij<x}
denotes the indicator function of the set {Xij < x}. Using the asymptotic equivalence
theorem, see for example Brunner and Munzel [3] or Brunner and Puri [4], it can be
shown that the statistic
TN =
√
N(pˆ− p), (2)
is asymptotically normal under slight regularity assumptions. Let us denote by
UN =
√
N
(
n−12
n2∑
j=1
F1(X2j)− n−11
n1∑
j=1
F2(X1j) + 1− 2p
)
(3)
the statistic that is an asymptotically equivalent statistic to TN , but based on independent
random variables. Then, under the null hypothesis H0 : F1 = F2, the variance of UN can
be written as
σ20 =
N2
n1n2
σ2 =
1
t(1− t)σ
2, (4)
where σ2 =
∫
F 21 dF1− 14 . This means, TN/σ0 has asymptotically the same distribution as
UN/σ0, but the distribution of the latter is asymptotically standard normal. To compute
the variance of TN under the alternative hypothesis, we again take advantage of this
asymptotic equivalence in (3) and obtain the following asymptotic variance σ2N under
alternative.
σ2N =
N
n1n2
(n2σ
2
1 + n1σ
2
2) (5)
where
σ21 = V ar(F2(X11)) =
∫
F 22 dF1 − (1− p)2, (6)
σ22 = V ar(F1(X21)) =
∫
F 21 dF2 − p2. (7)
Clearly, the variance σ2N under alternative is a weighted sum of two components, σ
2
1 and
σ22. Both of these components are important for minimizing the sample size, as performed
in Section 3, unlike the parametric case where only the two variances σ20 under the null
and σ21 under the alternative hypotheses are considered.
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Based on these considerations, an approximate sample size formula for the Wilcoxon-
Mann-Whitney test can be obtained similar to the one calculated by Wang et al. [29] for
continuous data. Namely, we obtain
N =
(
σ0u1−α/2 + σNu1−β
)2
(p− 1
2
)2
, (8)
where α and β denote the type-I and type-II error rates, respectively, and u1−α/2 is the
1− α/2 quantile of the standard normal distribution.
The quantities p, σ0, and σN in Equation (8) are unknown in general. Moreover, σ
2
N
is a linear combination of the two unknown variances σ21 and σ
2
2 in Equations (6) and
(7). To compute these quantities from the distribution F1 of the prior information in the
reference group and the distribution F2 generated by an intuitive and easy to interpret
relevant effect, we proceed as follows.
We interpret the distributions of the data as fixed theoretical distributions similar
to the parametric case in Seber [25] on page 433 and Puntanen et al. [21] on pages
27 and 28. Therefore, we denote the data from the prior information by X∗11, . . . , X
∗
1n1
and the synthetic data for the treatment group by X∗21, . . . , X
∗
2n2. The corresponding
cumulative distribution functions are denoted by F ∗1 (x) = Fˆ1(x) and F
∗
2 (x) = Fˆ2(x),
respectively. Here, Fˆ1(x) denotes the empirical distribution function of the available data
X∗11, . . . , X
∗
1n1
in the reference group and Fˆ2(x) the empirical distribution functions of the
synthetic data X∗21, . . . , X
∗
2n2
in the treatment group. In this context, “synthetic” means
that the data for F2 are artificially generated based on the prior information F1 and some
interpretable relevant effect. We can generate data sets of arbitrary size for F1 and F2,
as long as the relative frequencies or probabilities remain unchanged. Because we assume
that our synthetic data represent fixed distributions and not a sample, we can calculate
the variances σ21, σ
2
2, and σ
2, as well as the relative effect p exactly. To emphasis that
these quantities are not estimators but rather the true parameters based on the synthetic
data, we will denote these quantities by σ2∗, σ2∗1 , σ
2∗
2 , and p
∗.
By using the relations Nt = n1 and N(1 − t) = n2, the sample size formula from
Equation (8) is then rewritten as
N =
(
σ∗u1−α/2 + u1−β
√
tσ2∗2 + (1− t)σ2∗1
)2
t(1− t)(p∗ − 1
2
)2
. (9)
The variances and the relative effect can be easily calculated by using a simple relation
between ranks and the so-called placements P1k = n2Fˆ2(X1k) and P2k = n1Fˆ1(X2k), which
were introduced by Orban and Wolfe [20, 19]. The placements were first defined only
for continuous distributions, but were later generalized to include discrete distributions,
for details see, for example, Brunner and Munzel [3]. To this end, let R∗ik denote the
overall rank of X∗ik among all n1 + n2 = N synthetic data, and R
∗(i)
ik the ranks within
the i-th group, i = 1, 2. Further, let R
∗
i· =
1
ni
∑ni
k=1R
∗
ik, i = 1, 2, denote the rank
means. Then, the placements P ∗ik can be represented by these ranks as P
∗
ik = R
∗
ik −R∗(i)ik ,
i = 1, 2; k = 1, . . . , ni. Finally, by letting F
∗
i (x) = Fˆi(x), the quantities in the sample size
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formula (9) can be calculated directly as follows.
p∗ =
∫
F ∗1 dF
∗
2 =
1
N
(R
∗
2· − R
∗
1· ) +
1
2
, (10)
σ2∗ =
∫
F 2∗dF ∗ − 1
4
=
1
N3
2∑
i=1
ni∑
k=1
(
R∗ik −
N + 1
2
)2
, (11)
σ2∗1 =
∫
F 2∗2 dF
∗
1 − (1− p∗)2 =
1
n1n22
n1∑
k=1
(
P ∗1k − P
∗
1·
)2
, (12)
σ2∗2 =
∫
F 2∗1 dF
∗
2 − p∗2 =
1
n21n2
n2∑
k=1
(
P ∗2k − P
∗
2·
)2
. (13)
Note that for computing the variances, we do not divide by N −1 or ni−1, but rather
by N or ni, i = 1, 2 because the distributions of the synthetic data are considered as fixed
theoretical distributions similar to the parametric case in Puntanen et al. [21] (pages 27
and 28).
3. Minimizing N
3.1. Interval for the optimal design
In Section 2 we have derived a formula for the sample size N given type-I and type-II
error rates α and β, respectively. In practice, we sometimes have the opportunity to
choose how many subjects should be allocated to the first group and how many to the
second. The question in such a situation is how the proportion t = n1/N should be
chosen in order to minimize N . Bu¨rkner et al. [5] aimed at finding the optimal t such
that the power is maximized for a given sample size N . Although both questions lead to
essentially the same answer, we prefer to minimize the sample size as this question arises
more naturally in sample size planning.
Technically, an exact solution to this problem is possible, but it is not feasible to write
down the solution in closed form anymore, and it does not give us much information
about the behaviour of the solution. However, it is possible to provide an interpretable
interval for the optimal allocation rate t0 = argmint∈(0,1)N(t). For that, we only have to
assume that the power 1− β is greater than 50 % and we distinguish between the cases
σ1 = σ2 and σ1 6= σ2. Note that the variances σ21 and σ22 can be quite different even if
the variances of F1 and F2 are the same. If we allow unequal variances for F1 and F2 it
is even possible that σ21 = 0 and σ
2
2 = 1/4 occurs where 1/4 is the largest possible value
for the variances σ2i , i = 1, 2.
The assumption on the minimal power could be weakened to assuming that the numer-
ator of N(t) is not zero. One then only needs to distinguish the cases β > 1/2, β < 1/2,
and β = 1/2. For practical considerations, however, only β < 1/2 is of relevance, therefore
we only consider this situation.
Now regarding the case σ1 = σ2, it is clear from Formula (9) that the optimal allocation
rate is t0 = 1/2 because the numerator of N(t) does not depend on t and t(1 − t) is
maximized at t = 1/2. For the case σ1 6= σ2 we consider first 0 < σ1 < σ2. Then
it is possible to show (see Appendix, Result 2) that the sample size is minimized by a
t0 ∈ [I1, I2] with I1 ≤ I2 < 1/2. The minimizer is unique in the interval (0, 1) and the
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bounds I1 and I2 are given by
I1 =
1
κ+ 1
, (14)
I2 =
√
z√
z + (u1−α/2
√
qσ + u1−β σ22)
, (15)
where κ = σ2/σ1, σ
2 =
∫
F 21 dF1 − 1/4 as in (4), q = p(1− p), and
z =
(
u1−α/2
√
qσ + u1−β σ
2
1
) (
u1−α/2
√
qσ + u1−β σ
2
2
)
.
Additionally, the following equivalence holds
t0 <
1
2
⇐⇒ σ1 < σ2. (16)
In the case 0 < σ2 < σ1, we obtain an analogous result for the minimizer t0 ∈ [I2, I1],
where the bounds are the same as before. Moreover we have a similar equivalence, namely
t0 >
1
2
⇐⇒ σ1 > σ2. (17)
The derivation of these two equivalences can be found in the Appendix in the Results 2
and 3.
From the form of the interval [I1, I2] we can see that if κ ≈ 1 then t0 ≈ 1/2. In most
cases this means that the minimum total sample size N is obtained for allocation rates
close to 1/2, or the allocation rate is 1/2 because of rounding. Larger values for the
type-I error rate α or the power 1− β lead in general to more extreme values for t0, that
is |1/2 − t0| gets larger. This can be seen from the upper bound I2. By increasing α or
the power 1− β the bound I2 decreases (or increases for σ1 > σ2). Typically this means
that the difference |1/2 − t0| tends to get larger. Note that I2 is bounded from below
(above), that is t0 cannot become arbitrarily small (or large). The impact of α and β is
demonstrated in simulations in Section 5.
Next, we consider the case 0 = σ1 < σ2. In the same way as before, it is possible to
construct an interval for the optimal allocation rate t0 which is given by [I
(0)
1 , I2], where
the lower bound is
I
(0)
1 =
u1−α/2 σ
2u1−α/2 σ + u1−β σ2
, (18)
and the upper bound is the same as in the case 0 < σ1. More details are given in the
Appendix in Result 4. An analogous result can be obtained for 0 = σ2 < σ1.
Therefore, the value of t0 is mainly determined by κ which is the ratio of the standard
deviations σ1 and σ2 under the alternative hypothesis. This is qualitatively different from
the result of Dette and O’Brien [8] for the t-test in a parametric location-scale model,
where the optimal allocation value is determined by the ratio of standard deviations
under the null and under the alternative hypothesis. For the Wilcoxon-Mann-Whitney
test, the variance under null hypothesis is not really important for determining t0, in case
of continuous distributions, for example, the variance under null hypothesis is σ20 = 1/12.
3.2. Optimality of a Balanced Design
In the previous section, we have provided ranges for the optimal allocation proportion t0.
There are many situations, in which balanced designs are optimal or close to optimal. In
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this section, we will describe classes of situations in which a balanced design minimizes
the sample size. From Section 3.1 we know that
t0 =
1
2
⇐⇒ σ1 = σ2. (19)
The right hand side of this equivalence can be rewritten as
t0 =
1
2
⇐⇒ σ1 = σ2 ⇐⇒
∫
F 21 dF2 =
∫
(1− F2)2dF1. (20)
Bu¨rkner et al. [5] showed analytically that for symmetric and continuous distributions
with F2(x) = F1(x+ a) and a 6= 0, the minimal sample size is attained at t0 = 1/2. Such
distributions satisfy the integral equation∫
F 21 dF2 =
∫
(1− F2)2dF1. (21)
But the class of distributions satisfying Equation (21) is actually larger. Consider nor-
malized cumulative distribution functions F1, F2 for which an a ∈ R exists such that for
all x ∈ R the following equality holds
F1(a+ x) = 1− F2(a− x) . (22)
Further, let us assume 1−β > 0.5. Then, the minimum for N(t), t ∈ (0, 1), is attained
at t0 = 1/2. This means that (22) is a sufficient but not necessary condition for t0 = 1/2.
As an example for distributions that satisfy Equation (21) but not (22) consider F1 = F2
to be a non-symmetric distribution.
Note that we do not assume for (22) that the distributions are stochastically ordered
or symmetric. If we assume finite third moments then equation (22) only implies that
both distributions have the same variance and their skewness has opposite signs, that is,
νF1 = −νF2 if we denote with νFi the skewness of the distribution with cdf Fi, i = 1, 2.
Obviously, for a large class of distributions, the optimal allocation rate is exactly 1/2.
Bu¨rkner et al. [5] already noticed the robustness of the Wilcoxon-Mann-Whitney test
regarding the optimal allocation rate. When the optimal t0 is not equal to 1/2, it is
often close to 1/2. Furthermore, the exact choice of t typically only has a small influence
on the required total sample size. This applies not only to continuous and symmetric
distributions but in general to arbitrary distributions.
4. Data Examples
The generality of the approach proposed in this paper is demonstrated using different
data examples with continuous metric, discrete metric, and ordered categorical data. In
this section, we first describe the data sets. Then, the calculated sample sizes along with
the actual achieved power in comparison with other sample size calculation methods are
given. For all data sets, we used the prior information from one group (e.g., from a
previous study or from literature) to generate synthetic data for the second group based
on an interpretable effect specified by a subject matter expert. For ordered categorical
data, such an effect might be that a certain percentage of subjects in each category are
moved to a better or worse category. For metric data, it is possible to simply use a location
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shift as the effect of interest. Regardless on how the effects are chosen, in the end, they
all are translated into the so-called nonparametric relative effect which itself provides
for another interpretable effect quantification which might be useful for practitioners, in
addtion to, for example, a location shift effect.
For all examples, we used α = 0.05 as the type-I error rate and provide the output
from an R function which shows the optimal t, the sample size determined for each
group, and the ratio κ = σ2/σ1. Furthermore, we provide simulation results to assess
the actual achieved power. The R Code is given in the appendix. For calculating the
asymptotic Wilcoxon-Mann-Whitney test, we used the function rank.two.samples from
the R package rankFD [13]. For all simulations performed with the statistical software
R, we generated 104 data sets and used 0 as our starting seed value for drawing data sets
from the synthetic data. To compute the optimal allocation rate t0 and the sample sizes
for each group, the function WMWssp_Minimize from the R package rankFD [13] can be
used.
4.1. Number of Seizures in an Epilepsy Trial
The data for the placebo group of a clinical trial published in Thall and Vail [28] and
Leppik et al. [15] is shown in Table 1. As mentioned in the Introduction, a relevant effect
for a drug may be stated as a reduction of the number of seizures by 50%. A location-
shift model is clearly not appropriate for these data. Based on the specified relevant effect
size, we can generate synthetic data. They lead to a nonparametric relative effect p of
approximately 0.27 which is inserted into the sample size formula.
In order to have a power of at least 80%, we need 24 subjects in each group, according
to our method. When using the optimal t0 ≈ 0.49, we need n1 = 23 and n2 = 24 subjects.
In this case, the optimal allocation only reduces the total number of subjects needed by
one, in comparison with a balanced design. Applying Noether’s formula in this case yields
sample sizes n1 = n2 = 26. Table 2 presents results from a power simulation regarding the
different sample size recommendations. Here, Noether’s formula would lead to a slightly
overpowered study.
Method Sample Sizes n1/n2 Total Sample Size N Power
Balanced 24/24 48 0.802
Unbalanced 23/24 47 0.7956
Noether 26/26 52 0.8417
Table 2: Power simulation for the number of seizures.
4.2. Irritation of the Nasal Mucosa
In this study, two inhalable substances with different concentrations are compared with
regard to the severity of the nasal mucosa damage of rats (see Akritas, Arnold and
Brunner [1]). The severity of irritation is described using a defect score from 0 to 3 where
0 refers to no irritation and 3 to severe irritation. For the nasal mucosa data, we have
prior information for substance 1 with 2 ppm concentration. A pathologist suggests, for
example, that a worsening of one score unit for 25% of the rats in categories 0, 1, and
2 is a relevant effect. This means that 25% of the rats with score 0 will be assigned
score 1 and so forth. The resulting synthetic data set for substance 2 is given in Table 3.
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The original data set for substance 1 has been augmented by factor 4 in order to obtain
integer values of the samples sizes for the synthetic data for substance 2. The result
of the sample size calculation is not affected by this because the relative frequencies for
substance 1 remain unchanged.
Defect Score
0 1 2 3
Substance 1 64 12 4 0
Substance 2 48 25 6 1
Table 3: Number of rats with defect score 0, 1, 2, 3.
Based on the synthetic data in Table 3, the relative effect is p = 0.599. Performing a
sample size calculation with 1−β = 0.8 and balanced groups results in sample sizes n1 =
n2 = 85. For this data set, the ratio of variances κ is larger than 1, therefore it is beneficial
to assign fewer subjects to the first group (substance 1). To be more precise, the optimal
allocation rate t0 is approximately 0.49 which leads to sample sizes n1 = 83 and n2 = 87.
But as we can see, in both cases the total sample size is N = 170. If we apply Noether’s
formula [18], we arrive at n1 = n2 = 134 which is considerably larger than the estimated
minimal sample size based on our method and leads to a remarkably overpowered study,
with actual power of over 94% (see Table 4 for the simulation results). This is mainly due
to ties in the data. Recall that Noether’s formula was derived for continuous distributions.
Our method achieves 80% power for the balanced and unbalanced design. Tang [27]
derived a sample size formula for ordered categorical data. If we use his method, we
obtain that 86 rats per group are needed. The closeness of his result to ours may be
taken as confirmation that our unified approach produces appropriate results also in the
case of ordered categorical data.
Method Sample Sizes n1/n2 Total Sample Size N Power
Balanced 85/85 170 0.8027
Unbalanced 83/87 170 0.7999
Noether 134/134 268 0.9417
Tang 86/86 172 0.8045
Table 4: Power simulation for the nasal mucosa data.
4.3. Kidney Weights
In this placebo-controlled toxicity trial, female and male Wistar rats have been given a
drug in four different dose levels. The primary outcome is the relative kidney weight in
[h], that is the sum of the two kidney weights divided by the total body weight, and
multiplied by 1,000. For calculating the sample size we consider only male rats from
the placebo group and generate a suitable data set exhibiting a relevant effect for the
treatment group. For generating the synthetic data of the treatment group, an expert
considers a location shift of 5% of the mean from the placebo group as a relevant effect.
The data are displayed in Table 5.
Using the data from Table 5 as our synthetic data, the nonparametric relative effect is
calculated as p ≈ 0.70. Thus, we need n1 = n2 = 30 Wistar rats to have a power of at
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least 80%. In this example, there is again barely any difference between using the optimal
design t0 ≈ 0.51 (n1 = 31, n2 = 30) and a balanced allocation. Because of rounding,
in this case the optimal design even leads to a larger sample size N = 61 in comparison
to N = 60 obtained using a balanced design. Noether’s formula leads to sample sizes
n1 = n2 = 32 in this case. The simulated power is given in Table 6. Clearly, Noether’s
formula again exceeds the 80% power. Our method maintains the power quite well and
leads to just a slight inflation of power in the unbalanced design.
4.4. Albumin in Urine
This data set was considered by Lachin [14] and contains albumin levels in the urine
(albuminuria) of diabetic patients. The levels of albumin are rated as either normal,
microalbuminuria, or macroalbuminuria. The goal of the study was to compare two
treatments, with expected conditional probabilities as given in Table 7.
For 90% power, Lachin [14] reports a required sample size of N = 1757 (1758 because
of rounding to achieve balanced sample sizes). Using our proposed method, we obtain a
necessary total sample size of N = 1754 in the balanced case. For the optimal design,
we obtain N = 1751 with an optimal allocation rate t0 around 0.52. Simply using the
Noether formula despite the ties, one would calculate a required sample size of N = 5334
(!), clearly leading to a much overpowered study. The other three methods attain the
nominal power based on a simulation study. The relative effect for this data set is
p = 0.474.
In the above four data examples, we have used α = 0.05 and 1− β = 0.8 or 0.9 for the
sample size calculation and power simulation. According to Formula (9) and the intervals
for t0 (Equations (14) and (15) in Section 3.1), the choice of α and β has an influence not
only on the total sample size N , but also on the optimal allocation rate t0. In order to
study the behaviour of these two parameters, we have performed two simulation studies
which are described in Section 5.
5. Simulations for the Optimal Design
In this section, we assess in different simulations the behaviour of the optimal allocation
rate t0 when changing the nominal type-I error rate α, the power 1− β, and the ratio of
standard deviations κ = σ2/σ1.
For simulating the influence of α, we used Beta(5, 5) and Beta(3, 2) distributed random
numbers in the first and second group. For each α = 0.01, 0.02, . . . , 0.1, we generated
106 random numbers for each group and calculated the optimal allocation rate t0 and
the total sample sizes N(t0) and N(1/2) (corresponding to a balanced design) to achieve
at least 80% power. From the formula for the upper bound I2 of t0 we already saw
(Section 3.1) that larger values for the type-I error rate α would lead to a larger difference
|I2 − 1/2|. While we cannot conclude from this directly that t0 will be more extreme,
Relative Kidney Weight [h]
Placebo 6.62 6.65 5.78 5.63 6.05 6.48 5.50 5.37
Treatment 6.92 6.95 6.08 5.93 6.35 6.78 5.80 5.67
Table 5: Relative kidney weights [h] for 16 male Wistar rats.
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Method Sample Sizes n1/n2 Total Sample Size N Power
Balanced 30/30 60 0.7976
Unbalanced 31/30 61 0.8123
Noether 32/32 64 0.8320
Table 6: Power simulation for the relative kidney weights.
Normal Micro Macro
Control 0.85 0.10 0.05
Experimental 0.90 0.075 0.025
Table 7: Relative frequencies for the Albumin data from Lachin [14].
the optimal allocation rate will more likely tend to more extreme values, that is, the
difference |t0 − 1/2| tends to become larger. We can see this behaviour confirmed in
Table 9. In this simulation, we had p = 0.657 and κ = 1.53, implying t0 < 1/2. In the
data examples, we already found very little difference between using a balanced design
or the optimal design. The simulation study yielded a similar observation (see Table 9).
In a second simulation, we investigated the behaviour of t0 for increasing power (or
decreasing β). We used α = 0.05 and the same distributions as before. Therefore, p and
κ were the same as above. As power, we chose 1 − β = 0.6, . . . , 0.95 and generated 106
random numbers for each β to calculate the optimal allocation rate t0. The results are
displayed in Table 10. A larger power led to more extreme values for t0, but the difference
in required sample sizes between the balanced and optimal design was again negligible.
6. Discussion
In this paper, we propose a unified approach to sample size determination for theWilcoxon-
Mann-Whitney two sample rank sum test. Our approach does not assume any specific
type of data or a specific alternative hypothesis. In particular, data distributions may be
discrete, or continuous. Based on the general formula, we have also derived an optimal
allocation rate to both groups, that is, t = n1/N such that N is minimized. The value of
this optimal allocation rate t0 mainly depends on the ratio κ = σ2/σ1 (see (12) and (13)
for a definition of these variances) and on β. The variance under the null hypothesis has
no influence on t0. For κ > 1 we have t0 < 1/2, for κ < 1 we have t0 > 1/2, and for κ = 1
we have exactly t0 = 1/2 assuming u1−β > 0. The nominal type-I error rate α only has
a small impact on the value of t0. The larger α is, the larger is the difference |t0 − 1/2|.
We can see from the interval [I1, I2] for the optimal allocation rate t0 derived in Sec-
tion 3.1 that t0 will typically be close to 1/2. This was also confirmed in some illustrative
data examples in Section 4. Furthermore, the difference in required sample size between
using a balanced design and using the optimal allocation design appears practically neg-
ligible. In other words, in most cases, a balanced design can be recommended for the
Wilcoxon-Mann-Whitney test. In extensive simulations, we have confirmed that the new
procedure actually meets the power at the calculated sample sizes quite well. The new
procedure has been implemented into the R package WMWssp and will also be available
through the package rankFD [13].
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Method Sample Sizes n1/n2 Total Sample Size N Power
Balanced 877/877 1754 0.9054
Unbalanced 909/842 1751 0.9033
Lachin 879/879 1758 0.9029
Noether 2667/2667 5334 ≈ 1
Table 8: Power simulation for the albumin in urine data.
t0 N(t0) N(1/2) α
0.4761 153.0998 153.4463 0.01
0.4742 130.2582 130.6034 0.02
0.4724 118.1328 118.4890 0.03
0.4715 108.4745 108.8243 0.04
0.4704 102.7568 103.1146 0.05
0.4695 96.3878 96.7427 0.06
0.4687 91.8895 92.2473 0.07
0.4680 87.5307 87.8868 0.08
0.4673 82.7874 83.1389 0.09
0.4668 79.3812 79.7288 0.10
Table 9: Optimal allocation rate t0 and required total sample sizes for optimal alloca-
tion and balanced allocation. Power fixed at 80%. Underlying distributions
Beta(5, 5) and Beta(3, 2).
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A. R Code
A.1. Power Simulation
x1 # vector of synthetic data of first group
x2 # vector of synthetic data of second group
R <- 10^4
reject <- 0
n1 <- 299
n2 <- 299
set.seed(0)
for(i in 1:R){
z1 <- sample(x1, size = n1, prob = NULL, replace = TRUE)
z2 <- sample(x2, size = n2, prob = NULL, replace = TRUE)
df = data.frame(grp = c(rep(1,n1), rep(2,n2)), z = c(z1,z2))
df$grp <- as.factor(df$grp)
p <- rank.two.samples(z~grp, data = df, wilcoxon = "asymptotic", info = FALSE, shift.int=FALSE,
alternative = "two.sided")$Wilcoxon$p.Value
if(p <= 0.05){
reject <- reject + 1
}
}
A.2. Minimize t
x1 # vector of synthetic data of first group
x2 # vector of synthetic data of second group
alpha = 0.05
beta=0.8
m1 <- length(x1)
m2 <- length(x2)
# ranks among union of samples:
R <- rank(c(x1,x2), ties.method="average")
R1 <- R[1:m1]
R2 <- R[m1+(1:m2)]
# ranks within samples:
R11 <- rank(x1, ties.method="average")
R22 <- rank(x2, ties.method="average")
# placements:
P1 <- R1 - R11
P2 <- R2 - R22
# effect size:
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pStar <- (mean(R2)-mean(R1)) / (m1+m2) + 0.5
# variances:
sigmaStar <- sqrt(sum((R11-((m1+1)/2))^2) / m1^3)
sigma1Star <- sqrt(sum((P1-mean(P1))^2) / (m1*m2^2))
sigma2Star <- sqrt(sum((P2-mean(P2))^2) / (m1^2*m2))
sigmaStar <- sqrt(sum( (R- (m1+m2+1)/2)^2 )/(m1+m2)^3)
ss = function(t){
return((sigmaStar*qnorm(1-alpha/2) + qnorm(beta)*sqrt(t*sigma2Star^2 +
(1-t)*sigma1Star^2))^2 / (t*(1-t)*(pStar-0.5)^2))
}
# sample size with balanced groups
ss(1/2)
# optimal t
optimize(ss,interval=c(0,1), maximum=FALSE,tol = .Machine$double.eps)$minimum
# sample size given optimal t
optimize(ss,interval=c(0,1), maximum=FALSE,tol = .Machine$double.eps)$objective
B. Derivation of the Results
B.1. Interval for the Optimal Design
Result 1. If we assume σ1 = σ2 and 1 − β > 0.5 then the optimal design is given by
t0 =
1
2
. It is not necessary to assume 1 − β > 0.5 but it is convenient to do so in order
to avoid a situation where N(t) = 0 for all t ∈ (0, 1).
Proof. The numerator of N(t) does not depend on t in this case, therefore N(t) is mini-
mized by t0 =
1
2
.
Result 2. For 1 − β > 0.5 and 0 < σ1 < σ2 the sample size is minimized by t0 ∈ [I1, I2]
with I1 ≤ I2 < 12 . The minimizer is unique in the interval (0, 1). The bounds I1 and I2
are given by
I1 =
1
κ + 1
, (23)
I2 =
√
z√
z +
(
u1−α/2
√
qσ + u1−βσ22
) , (24)
with κ = σ2/σ1, q = p(1 − p) and z =
(
u1−α/2
√
qσ + u1−βσ
2
1
) (
u1−α/2
√
qσ + u1−βσ
2
2
)
.
Additionally the following equivalence holds
t0 <
1
2
⇐⇒ σ1 < σ2. (25)
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Proof. First we calculate the derivative of N which is given by
d
dt
N(t) =
(
u1−α/2 σ + uβ
√
σ21 (1− t) + σ22 t
) g(t)
f(t)
, (26)
where the functions f and g are defined by
g(t) = u1−α/2 σ(2t− 1)
√
σ21 (1− t) + σ22 t− uβ
(
σ21 (1− t)2 − σ22 t2
)
,
f(t) = (p− 1
2
)2(1− t)2t2
√
σ21(1− t) + σ22t2.
Only g(t) has a root in (0, 1). Therefore, we only need to consider this function for finding
the optimal t0. To prove the equivalence we start with t0 <
1
2
. In this case, t0 > λ =
1
κ+1
.
Because 1
2
> t0 > λ it follows that κ > 1. The other direction can be proved in a similar
manner.
Now that we know t0 <
1
2
we can easily construct an interval for t0. A lower bound is
given by λ. For the upper bound we use the monotonic function
h(t) = u1−α/2 σ(2t− 1)√q − uβ
(
σ21(1− t)2 − σ22t2
)
. (27)
This function satisfies h(t) < g(t) for all t ∈ (0, 1
2
) and it has exactly one root I2 in (0,
1
2
).
From this it immediately follows that t0 < I2.
For the uniqueness in (0, 1), consider a second solution t′0 ≤ t0. It follows immediately
that t′0 > λ and consequently λ ≤ t′0 ≤ t0 ≤ 12 . But g is strictly monotone in (0, 12),
therefore both roots are equal.
Result 3. For 1 − β > 0.5 and σ1 > σ2 > 0 the sample size is minimized by t0 ∈ [I2, I1]
with I1 ≥ I2 > 12 . The minimizer is unique in the interval (0, 1). The bounds are the
same as in the previous theorem. Additionally the following equivalence holds
t0 >
1
2
⇐⇒ σ1 > σ2. (28)
Proof. Similar proof as in the case 0 < σ1 < σ2.
Result 4. For the case σ1 = 0 < σ2, we cannot apply the result from before. But using
a similar idea we can find a lower bound l(t) for the function g(t) which is defined by
l(t) = u1−α/2 σ(2t− 1)σ2 t+ uβ σ22 t2 (29)
and this function only has one root in (0, 1), namely
I
(0)
1 =
u1−α/2 σ
2u1−α/2 σ + u1−β σ2
=
1
2 + γ
, (30)
where γ = u1−β σ2
/ (
u1−α/2 σ
)
. Then an interval for the optimal design is given by
[I
(0)
1 , I2].
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B.2. Optimality of a Balanced Design
From the construction of an interval for t0 it is clear that t0 = 1/2 if and only if σ
2
1 = σ
2
2 .
The equality of variances simply means∫
F 22 dF1 −
(∫
F2dF1
)2
=
∫
F 21 dF2 −
(∫
F1dF2
)2
. (31)
From that we can easily conclude the equivalence
t0 =
1
2
⇐⇒
∫
F 21 dF2 =
∫
(1− F2)2dF1. (32)
Result 5. Let us now consider normalized cumulative distribution functions F1, F2 for
which an a ∈ R exists such that for all x ∈ R Equation (22) holds, that is,
F1(a + x) = 1− F2(a− x). (33)
Then the optimal design is given by t0 = 1/2. Furthermore if such an a exists and
the expectations of the two distributions are finite, then the constant a can be explicitly
calculated as
a =
1
2
(∫
xdF1(x) +
∫
xdF2(x)
)
, (34)
that is, a is the average of the expected values. If the third moments are finite, then it
follows from (22) that the variances of the distributions F1 and F2 are equal and their
skewness have opposite sign. In the case F1 = F2, the assumption (22) simply means that
F1 is a symmetric distribution.
Proof. This equivalence holds since F1 and F2 satisfy
∫
F 21 dF2 =
∫
(1−F2)2dF1. Equation
(34) follows directly after some calculations by first considering F1 and F2 to be either
continuous or discrete. Then (34) also holds for distributions with a continuous and
discrete proportion. First we proof (34) for the discrete case. Note that from (22) we
can conclude that P (X1 = x) = P (X2 = 2a− x) holds. Then for discrete X1 ∼ F1 and
X2 ∼ F2 the result follows from
EX1 =
∑
i
xiP (X1 = xi)
= −
∑
i
(2a− xi)P (X2 = 2a− xi) + 2a = −EX2 + 2a .
The derivation for the continuous case is similar.
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